---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-085144"
form_type: "8-K"
ticker: "SPRB"
cik: "0001683553"
company_name: "SPRUCE BIOSCIENCES, INC."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:47:58.166841+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Spruce Biosciences wins Nasdaq appeal; must regain bid price compliance by Aug 5

## Summary
- Received Nasdaq delisting notice April 22, 2025; stock moved to OTC Pink on April 29, 2025.
- On June 9, 2025, Nasdaq Hearings Panel accepted appeal; stock may resume on Nasdaq Capital Market if compliance met by August 5, 2025.
- Panel retains jurisdiction until October 20, 2025; any future non-compliance must be reported to the panel.
- Company seeks stockholder approval for reverse stock split (1:50 to 1:100) at July 22, 2025 annual meeting to cure bid price deficiency.

## SEC filing metadata
- accession: 0000950170-25-085144
- form_type: 8-K
- ticker: SPRB
- cik: 0001683553
- company_name: SPRUCE BIOSCIENCES, INC.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1683553/000095017025085144/0000950170-25-085144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1683553/000095017025085144/sprb-20250609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-085144
- JSON: https://secwatch.observer/filing/0000950170-25-085144.json
- Plain text: https://secwatch.observer/filing/0000950170-25-085144.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.